Stay updated on CPX-351 and Quizartinib in AML Clinical Trial
Sign up to get notified when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.

Latest updates to the CPX-351 and Quizartinib in AML Clinical Trial page
- ChecktodayChange DetectedThe study record history now shows Revision: v3.6.5 as the latest entry, replacing Revision: v3.6.4, indicating an update to the page's revision history.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study history page now shows a new revision tag v3.6.4, replacing the previous v3.6.3, signaling a software update to the site’s interface.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe Record History now lists the latest software revision as v3.6.3, replacing the previous v3.6.2 entry to reflect a deployment update.SummaryDifference0.1%

- Check43 days agoChange DetectedNew revision entry v3.6.2 has been added to the study record history, indicating an updated version of the record. The previous revision v3.6.0 is removed in this update, reflecting the revised history list.SummaryDifference0.1%

- Check58 days agoChange DetectedThe latest history entry records that the study is no longer enrolling participants and notes a revision to v3.6.0; the previous revision v3.5.5 is removed from the visible history.SummaryDifference0.3%

- Check65 days agoChange DetectedThe study record history shows an update on 2026-06-02 changing the status to Active, not recruiting and adding new sections for Contacts/Locations, Study Status, and Recruitment Status. This update is tracked under revision v3.5.5, replacing the previous v3.5.4 which listed Recruiting.SummaryDifference0.7%

Stay in the know with updates to CPX-351 and Quizartinib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.